Back to Trades
SETH SANDESH
Chief Executive OfficerDirectorCIK 0001566175
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Across 2 filings between 2025–2026, SETH SANDESH, Chief Executive Officer, Director, has disclosed $1.3M in transactions — all concentrated in Actinium Pharmaceuticals, Inc. (ATNM). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Sep 4 | ATNM Actinium Pharmaceuticals, Inc. | SETH SANDESH | Chief Executive Officer, Director | Grant | $1.1M |
| Aug 20 | ATNM Actinium Pharmaceuticals, Inc. | SETH SANDESH | Chief Executive Officer, Director | Tax withheld | $206.7K |
2 filings